Storage and handling
Other information read the directions and warnings before use keep the carton. It contains important information. store at 20°-25°C (68°-77°F) protect from moisture FDA approved dissolution test specifications differ from USP
Other information read the directions and warnings before use keep the carton. It contains important information. store at 20°-25°C (68°-77°F) protect from moisture FDA approved dissolution test specifications differ from USP
Active ingredient (in each tablet)
Famotidine USP 20 mg
Purpose
Acid reducer
Uses
Warnings
Allergy alert: Do not use if you are allergic to famotidine or other acid reducers
Do not use
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking a prescription drug. Acid reducers may interact with certain prescription drugs.
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Directions
adults and children 12 years and over:
children under 12 years: ask a doctor
Other information
Inactive ingredients carnauba wax, colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, pregelatinized starch, talc, titanium dioxide
Questions or comments? Call 1-800-910-6874
JUST ONE TABLET prevents and relieves heartburn due to acid indigestion brought on by eating and drinking certain foods and beverages
Tips for Managing Heartburn
| Class | Version | Type | Effective |
|---|---|---|---|
| FAMOTIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae | Product name | 7 | 20260317 |
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| cf645750-2e70-f6e1-c05a-a52847def5dd | Product name | 9 | 20250312 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 4fdc761c-585e-054b-8ebe-86130a26e4c1 | Product name | 2 | 20221205 |
| fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-697-01 | Maximum Strength Acid Reducer | 2 in 1 CARTON | TABLET | 2 | 2 | |
| 11673-697-01 | Maximum Strength Acid Reducer | 50 in 1 BOTTLE | TABLET | 50 | 2 | |
| 11673-697-05 | Maximum Strength Acid Reducer | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 11673-697-05 | Maximum Strength Acid Reducer | 50 in 1 BOTTLE | TABLET | 50 | 2 | |
| 11673-697-20 | Maximum Strength Acid Reducer | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 11673-697-20 | Maximum Strength Acid Reducer | 200 in 1 BOTTLE | TABLET | 200 | 2 | |
| 11673-697-52 | Maximum Strength Acid Reducer | 5 in 1 BLISTER PACK | TABLET | 5 | 2 | |
| 11673-697-52 | Maximum Strength Acid Reducer | 5 in 1 CARTON | TABLET | 5 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11673-697 | 11673-697-52, 11673-697-05, 11673-697-01, 11673-697-20 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| TALC | 7SEV7J4R1U | IACT |
| MICROCRYSTALLINE CELLULOSE 102 | PNR0YF693Y | IACT |
| FAMOTIDINE | 5QZO15J2Z8 | ACTIB |
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| HYDROXYPROPYL CELLULOSE, UNSPECIFIED | 9XZ8H6N6OH | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217543-001 | FAMOTIDINE | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | ||
| A217543-002 | FAMOTIDINE | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A217543-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2023-03-08 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A217543-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2023-03-08 | a72a2bbeb626… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Maximum Strength Acid Reducer | FAMOTIDINE | TARGET CORPORATION | 07a924f1-14cc-4e7d-e063-6394a90ac7f3 | 2024-05-13 | Warnings | 11673-697-20 11673-697-01 11673-697-05 11673-697-52 11673-697 11673069752 11673069705 11673069701 11673069720 18567eaf-6b97-8c6f-e063-6294a90a986d 07a924f1-14cc-4e7d-e063-6394a90ac7f3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.